AMB-020

N/A

Report date: 2023/08/09 11:39:04
NME

Base Information

Drug NameAMB-020
Drug Alias NameAMB020AMB-020
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAimed Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAimed Bio Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A